Mia's Feed
Medical News & Research

Effective High Blood Pressure Treatment May Lower Dementia Risk

Effective High Blood Pressure Treatment May Lower Dementia Risk

Share this article

2 min read

Recent research highlights the potential of managing high blood pressure to significantly reduce the risk of developing dementia. A comprehensive phase 3 clinical trial involving nearly 34,000 participants demonstrated that intensive blood pressure control not only improves cardiovascular health but also has a protective effect against cognitive decline. The study, published in Nature Medicine, indicates that patients with hypertension who received targeted treatment experienced a 15% reduction in all-cause dementia and a 16% decrease in cognitive impairment over four years.

The trial involved rural Chinese communities where participants aged 40 and above with untreated hypertension were divided into intervention and control groups. Those in the intervention group received antihypertensive medications, health coaching, and guidance on lifestyle modifications such as weight loss, reduced sodium intake, and alcohol moderation. This group showed markedly better blood pressure control compared to the usual care group, with a corresponding reduction in dementia risk.

Given the rising global prevalence of dementia—projected to reach 152.8 million by 2050—these findings underscore the importance of implementing widespread blood pressure management strategies. Lifestyle changes are also vital in tackling the growing dementia burden. Prior research underscores that untreated hypertension increases dementia risk by 42% over a lifetime.

The study's results support the idea that aggressive blood pressure control, facilitated by community health interventions, could be a crucial step toward reducing the worldwide impact of dementia. Scaling up such strategies may help mitigate the disease's future burden, especially in low- and middle-income countries where the largest increases are expected.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Unique Breathing Patterns as Personal Health Signatures: The Future of Respiratory Biometrics

Scientists have discovered that each person’s breathing pattern is unique and can be used as a biometric identifier, offering new insights into health and mental well-being.

How Lymphoma Rewires the Human Genome

Recent advances reveal how chromosomal translocations in lymphoma can cause widespread genome rewiring, activating multiple genes and promoting cancer progression. Learn about the latest findings in lymphoma genetics and potential targeted therapies.

Novo Nordisk Acquires US BioTech Leader Akero for $4.7 Billion to Advance Metabolic Disease Treatments

Novo Nordisk has acquired US biotech firm Akero Therapeutics for $4.7 billion, aiming to develop groundbreaking treatments for metabolic diseases like fatty liver and obesity. The deal emphasizes innovation in managing liver damage and expanding therapies for millions worldwide.

Recall Issued for Over 1,000 Pounds of Ground Beef in Five States Due to Metal Contamination

Over 1,000 pounds of frozen ground beef have been recalled across five states after reports of metal fragments being found in the product. No injuries have been reported yet.